Varying effects of intravenous immunoglobulin on mononuclear cell proliferation in vitro

Journal of Korean Medical Science

Volumn 16, Issue 5, 2001, Pages 544-548

  Lee, Kyung Yil ^a   Koh, Dae Kyun ^a,b   Lee, Joon Sung ^a   Whang, Kyung Tae ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Immunoglobulins, Intravenous; Nuclear Antigen; Proliferating Cell

Indexed keywords

IMMUNOGLOBULIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG EFFECT; HUMAN; MONONUCLEAR CELL; PHYSIOLOGY;

CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LEUKOCYTES, MONONUCLEAR; TETRADECANOYLPHORBOL ACETATE;

EID: 0035490576     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.5.544     Document Type: Article

References (24)

1. Buckley RH, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991; 325: 110-7.
2. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, et al. High dose intravenous gamma globulin for Kawasaki disease. Lancet 1984; 2 (8411): 1055-8.
3. Immbach P, Barandura S, D'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schoni M, Vest M, Wagner HP. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1 (8232): 1228-30.
4. Kimberly RP, Salmon JE, Bussel JB, Crow MK, Hilgartner NW. Modulation of mononuclear phagocyte function by intravenous gamma-globulin. J Immunol 1984; 132: 745-50.
5. Kurlander RJ. Reversible and irreversible loss of receptor function of human monocytes as a consequence of interaction with immunoglobulin G. J Clin Invest 1980; 66: 773-81.
6. Tomino Y, Sakai H, Takaya M, Miura M, Suga T, Endoh M, Nomoto Y. Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis. Clin Exp Immunol 1984; 58: 42-8.
7. Sultan Y, Kazatchkine MD, Maisoneuve P, Nydegger UE. Antiidiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high dose intravenous gammaglobulin. Lancet 1985; 2: 765-8.
8. Andersson JP, Andersson UG. Human intravenous immunoglobulin modulates monokine production in vitro. Imunology 1990; 71: 372-6.
9. Amran D, Renz H, Lack G, Bradley K, Gelfand EW. Suppression of cytokines-dependent human T-cell proliferation by intravenous im-munoglobulin. Clin Immunol Immunopathol 1994; 73: 180-6.
10. Stohl W. Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Clin Exp Immunol 1985; 62: 200-7.
11. Dammacco F, Iodice G, Campobasso N. Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro. Br J Haematol 1986; 62: 125-35.
12. Kondo N, Ozawa T, Mushiake K, Motoyoshi F, Kameyama T, Kasahara K, Kaneko H, Yamashina M, Kato M, Orii T. Suppression of immuno-glibulin production of lymphocytes by intravenous im-munoglobulin. J Clin Immunol 1991; 11: 152-8.
13. Dietrich G, Pereira P, Algiman M, Sultan Y, Kazatchkine MD. A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines an idiotype that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIG). J Autoimmun 1990; 3: 547-57.
14. Takeai S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993; 91: 602-5.
15. Kawada K, Terasaki PI. Evidence for immunossupression by high-dose gammaglobulin. Exp Hematol 1987; 15: 133-6.
16. Van Schaik IN, Lundkvist I, Vermeulen M, Brand A. Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro. J Clin Immunol 1992; 12: 325-34.
17. Klaesson S, Ringden O, Markling L, Remberger M, Lundkvist I. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro. Scand J Immunol 1993; 38: 477-84.
18. Andersson UG, Bjork L, Skansen-Saphir U, Andersson JP. Down-regulation of cytokine production and IL-2 receptor expression by pooled human IgG. Immunology 1993; 79: 211-6.
19. Hashimoto F, Sakiyama Y, Matsumoto S. The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglibulin production. Clin Exp Immunol 1986; 65: 409-15.
20. Nachbaur D, Herold M, Eibl B, Glassl H, Schwaighofer H, Huber C, Gachter A, Pichl M, Niederwieser D. A comparative study of the in vitro immunomodulatory activity of human intact immuno-globulin (7S IVIG), F (ab′), fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation. Immunology 1997; 90: 212-8.
21. Prasad, NK, Papoff G, Zeuner A, Bonnin E, Kazaichkine MD, Roberti G, Kaveri VS. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway. J Immunol 1998; 161: 3781-90.
22. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE. Inhibition of toxic epidermal necrosis by blockade of CD 95 with human intravenous immuno-globulin. Science 1998; 282: 490-3.
23. Alder LBA, Morgan LA, Spickett GP. Contribution of stablizing agent present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro. Scand J Immunol 1996; 44: 585-91.
24. Newburger JW, Takahashi M, Beiser AS, Bums JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, et al. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Eng J Med 1991; 324: 1633-9.